Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.02 USD | +1.02% | +0.86% | +17.66% |
Apr. 19 | Nephron Research Raises Boston Scientific's Price Target to $80 From $75 | MT |
Apr. 17 | FDA classifies recall of Boston Scientific device as 'most serious' | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.66% | 99.98B | |
+3.31% | 209B | |
+2.05% | 175B | |
+9.36% | 131B | |
-1.71% | 61.12B | |
+14.05% | 52.34B | |
-4.15% | 46.5B | |
-3.68% | 39.24B | |
+9.04% | 38.47B | |
+4.84% | 26.49B |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Canaccord Genuity Adjusts Price Target on Boston Scientific to $58 From $53, Maintains Buy Rating